US homebuilder sentiment plunges as high mortgage rates, economic uncertainty, and supply chain issues weaken housing demand and spur price cuts.
Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
Tron, led by Justin Sun, is preparing to go public in the U.S. through a reverse merger, with potential Trump family involvement, causing a surge in TRX and broader crypto market.
US homebuilder sentiment plunges as high mortgage rates, economic uncertainty, and supply chain issues weaken housing demand and spur price cuts.
Eli Lilly acquires gene-editing biotech Verve Therapeutics for $1.3 billion, expanding its pipeline in cardiovascular therapies.
Tron, led by Justin Sun, is preparing to go public in the U.S. through a reverse merger, with potential Trump family involvement, causing a surge in TRX and broader crypto market.